CVS Health Corp
Research CVS Health Corp (CVS) on Bullrun: valuation model: 17.8% overvalued, market cap USD 110.11B, P/E 22.7, dividend yield 3.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCVS
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryHealthcare Plans
- CurrencyUSD
- Valuation signal17.8% overvalued
- Market capUSD 110.11B
- P/E22.7
- Dividend yield3.0%
- Financial periodQ2 2026
- RevenueUSD 106.10B
- Net incomeUSD 2.98B
- Free cash flowUSD 5.65B
- Gross margin14.8%
Valuation Snapshot
Bullrun's latest valuation model marks CVS Health Corp as 17.8% overvalued; latest market cap is USD 110.11B; P/E is 22.7; dividend yield is 3.0%.
Peer valuation comparison
Latest P/E is 22.75x versus a Healthcare sector median of 24.61x (7.6% below).
Latest dividend yield is 3.04% versus a Healthcare sector median of 1.84% (65.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 402.07B | USD 1.77B | USD 7.81B | 45.0% | 1.39 | USD 8.45B | USD 0 | USD 75.21B |
| FY2024 | USD 372.81B | USD 4.61B | USD 6.33B | 44.7% | 3.66 | USD 8.59B | USD 2.12B | USD 75.56B |
| FY2023 | USD 357.78B | USD 8.34B | USD 10.40B | 39.3% | 6.47 | USD 8.20B | USD 200.00M | USD 76.46B |
| FY2022 | USD 322.47B | USD 4.31B | USD 13.45B | 38.9% | 3.26 | USD 12.95B | USD 0 | USD 71.47B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 110.11B | 22.7 | 3.1% | 2.67 |
| 2025 | 2025-12-31 | USD 100.87B | 57.5 | 3.4% | 2.68 |
| 2024 | 2024-12-31 | USD 56.56B | 12.3 | 6.0% | 2.68 |
| 2023 | 2023-12-29 | USD 101.61B | 11.9 | 3.1% | 2.44 |
| 2022 | 2022-12-30 | USD 122.45B | 37.9 | 2.4% | 2.2 |
| 2021 | 2021-12-31 | USD 136.38B | 17.3 | 1.9% | 2 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.67 USD, yield 3.0%.
| Year | Dividends/share |
|---|---|
| FY2025 | 2.66 USD |
| FY2024 | 2.66 USD |
| FY2023 | 2.42 USD |
| FY2022 | 2.2 USD |
About CVS Health Corp
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services.
ETFs that hold CVS Health Corp
CVS Health Corp is one of the ten largest holdings of 4 ETFs that investors in Europe can buy, most traded first:
| ETF | Weight | TER |
|---|---|---|
| WisdomTree US Equity Income UCITS ETF | 2.91% | 0.29% |
| WisdomTree US High Dividend UCITS ETF - Acc | 2.91% | 0.29% |
| WisdomTree US High Dividend UCITS ETF - EUR Hedged Acc | 2.91% | 0.35% |
| WisdomTree US High Dividend UCITS ETF - GBP Hedged Acc | 2.52% | 0.35% |
Related stock research
Other Healthcare stocks
Frequently asked questions
Is CVS Health Corp overvalued or undervalued?
Bullrun's valuation model currently marks CVS Health Corp as 17.8% overvalued.
What is CVS Health Corp's market cap?
CVS Health Corp's market capitalization is USD 110.11B.
What is CVS Health Corp's P/E ratio?
CVS Health Corp's price-to-earnings (P/E) ratio is 22.7.
Does CVS Health Corp pay a dividend?
CVS Health Corp has a dividend yield of 3.0%.
What does CVS Health Corp do?
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services.